Have your own idea? Try our Stock Screener
Canadian (TSX) Drug Retail Industry Analysis
UpdatedApr 17, 2025
DataAggregated Company Financials
Companies2
- 7D2.8%
- 3M14.7%
- 1Y22.7%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 2.8%, driven by pullbacks from every company within the industry. This takes the industry's 12 month performance to a gain of 26%. As for the next few years, earnings are expected to grow by 76% per annum.
Industry Valuation and Performance
Has the Canadian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 17 Apr 2025 | CA$221.8m | CA$368.1m | -CA$6,489,338.00 | n/a | -34.2x | 0.6x |
| Sat, 15 Mar 2025 | CA$218.3m | CA$368.1m | -CA$6,489,338.00 | n/a | -33.6x | 0.6x |
| Mon, 10 Feb 2025 | CA$210.8m | CA$367.0m | -CA$7,944,338.00 | n/a | -26.5x | 0.6x |
| Wed, 08 Jan 2025 | CA$184.0m | CA$367.0m | -CA$7,944,338.00 | n/a | -23.2x | 0.5x |
| Fri, 06 Dec 2024 | CA$188.4m | CA$367.0m | -CA$7,944,338.00 | n/a | -23.7x | 0.5x |
| Sun, 03 Nov 2024 | CA$200.9m | CA$366.8m | -CA$8,148,267.00 | n/a | -24.7x | 0.5x |
| Tue, 01 Oct 2024 | CA$193.7m | CA$366.8m | -CA$8,148,267.00 | n/a | -23.8x | 0.5x |
| Thu, 29 Aug 2024 | CA$167.6m | CA$366.6m | -CA$7,621,633.00 | n/a | -22x | 0.5x |
| Sat, 27 Jul 2024 | CA$151.8m | CA$369.1m | -CA$4,361,633.00 | n/a | -34.8x | 0.4x |
| Mon, 24 Jun 2024 | CA$138.3m | CA$369.1m | -CA$3,773,000.00 | n/a | -36.6x | 0.4x |
| Wed, 22 May 2024 | CA$127.5m | CA$369.1m | -CA$3,773,000.00 | n/a | -33.8x | 0.3x |
| Fri, 19 Apr 2024 | CA$131.8m | CA$370.7m | -CA$5,405,000.00 | n/a | -24.4x | 0.4x |
| Sun, 17 Mar 2024 | CA$958.2m | CA$1.2b | -CA$38,106,000.00 | n/a | -25.1x | 0.8x |
| Tue, 13 Feb 2024 | CA$914.3m | CA$1.2b | -CA$43,234,000.00 | n/a | -21.1x | 0.7x |
| Thu, 11 Jan 2024 | CA$818.4m | CA$1.2b | -CA$43,234,000.00 | n/a | -18.9x | 0.7x |
| Sat, 09 Dec 2023 | CA$897.1m | CA$1.2b | -CA$32,998,000.00 | n/a | -27.2x | 0.7x |
| Mon, 06 Nov 2023 | CA$891.2m | CA$1.2b | -CA$33,343,000.00 | n/a | -26.7x | 0.7x |
| Wed, 04 Oct 2023 | CA$644.2m | CA$1.2b | -CA$33,343,000.00 | n/a | -19.3x | 0.5x |
| Fri, 01 Sep 2023 | CA$805.6m | CA$1.2b | -CA$33,343,000.00 | n/a | -24.2x | 0.7x |
| Sun, 30 Jul 2023 | CA$835.2m | CA$1.1b | -CA$49,239,000.00 | n/a | -17x | 0.7x |
| Tue, 27 Jun 2023 | CA$857.4m | CA$1.1b | -CA$54,206,633.00 | n/a | -15.8x | 0.8x |
| Thu, 25 May 2023 | CA$1.1b | CA$1.1b | -CA$40,586,633.00 | n/a | -26x | 1x |
| Sat, 22 Apr 2023 | CA$1.1b | CA$1.1b | -CA$41,199,633.00 | n/a | -26.1x | 1x |
| Mon, 20 Mar 2023 | CA$1.1b | CA$1.1b | -CA$70,486,307.00 | n/a | -15.7x | 1x |
| Wed, 15 Feb 2023 | CA$1.2b | CA$1.1b | -CA$41,345,953.00 | n/a | -28.4x | 1.1x |
| Fri, 13 Jan 2023 | CA$1.2b | CA$849.1m | -CA$36,693,953.00 | 371.8x | -31.9x | 1.4x |
| Sun, 11 Dec 2022 | CA$1.1b | CA$849.1m | -CA$36,693,953.00 | 369.8x | -31.3x | 1.4x |
| Tue, 08 Nov 2022 | CA$1.2b | CA$821.8m | -CA$42,878,845.00 | 374x | -27.3x | 1.4x |
| Thu, 06 Oct 2022 | CA$1.1b | CA$821.8m | -CA$42,878,845.00 | 351.2x | -26x | 1.4x |
| Sat, 03 Sep 2022 | CA$1.1b | CA$821.8m | -CA$42,878,845.00 | 323.7x | -25x | 1.3x |
| Mon, 01 Aug 2022 | CA$1.2b | CA$744.3m | -CA$104,337,767.00 | n/a | -11.6x | 1.6x |
| Wed, 29 Jun 2022 | CA$1.3b | CA$744.3m | -CA$104,337,767.00 | n/a | -12.2x | 1.7x |
| Fri, 27 May 2022 | CA$1.1b | CA$715.2m | -CA$82,721,767.00 | n/a | -12.8x | 1.5x |
| Sun, 24 Apr 2022 | CA$1.2b | CA$661.1m | -CA$74,470,000.00 | n/a | -15.9x | 1.8x |
Price to Earnings Ratio
-15.9x
Current Industry PE
- There are only 2 companies in the Canadian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 18% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Canadian Drug Retail compare with similar industries?
| CA Market | 2.09% | |
| Consumer Staples | 4.71% | |
| Food and Staples Retail | 5.09% | |
| Drug Retail | 2.80% | |
| Food Retail | 5.11% | |
| Food Distributors | 1.03% | |
| Big Box Super Stores | 0% | 0 |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PCRX PharmaCorp Rx | CA$0.48 | 4.3% +CA$2.3m | n/a | PS40.3x | |
| CRRX CareRx | CA$2.62 | 0.8% +CA$1.3m | 19.1% | PS0.4x |